Pound foolish and penny wise-when will dosing of rifampicin be optimised?

Cecile Magis-Escurra; Richard M. Anthony; Adri G. M. van der Zanden; Dick van Soolingen; Jan-Willem C. Alffenaar

doi:10.1016/S2213-2600(18)30044-4

Pound foolish and penny wise-when will dosing of rifampicin be optimised?

Cecile Magis-Escurra^*, Richard M. Anthony, Adri G. M. van der Zanden, Dick van Soolingen, Jan-Willem C. Alffenaar

^*Corresponding author for this work

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Letter › Academic › peer-review

12 Citations (Scopus)

31 Downloads (Pure)

Original language	English
Pages (from-to)	E11-E12
Number of pages	2
Journal	The Lancet. Respiratory Medicine
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(18)30044-4
Publication status	Published - Apr-2018

Keywords

TUBERCULOUS MENINGITIS
INTENSIFIED REGIMEN
MOXIFLOXACIN
TRIAL
RESISTANCE

Access to Document

10.1016/S2213-2600(18)30044-4

Pound foolish and penny wiseFinal publisher's version, 164 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{b9461fa4e9e646d6abe533b2cdf0c248,

title = "Pound foolish and penny wise-when will dosing of rifampicin be optimised?",

keywords = "TUBERCULOUS MENINGITIS, INTENSIFIED REGIMEN, MOXIFLOXACIN, TRIAL, RESISTANCE",

author = "Cecile Magis-Escurra and Anthony, {Richard M.} and {van der Zanden}, {Adri G. M.} and {van Soolingen}, Dick and Alffenaar, {Jan-Willem C.}",

year = "2018",

month = apr,

doi = "10.1016/S2213-2600(18)30044-4",

language = "English",

volume = "6",

pages = "E11--E12",

journal = "The Lancet. Respiratory Medicine",

issn = "2213-2600",